Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis


Raia, V., Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Auricchio, S., Cimmino, M., Cavaliere, M., Nardone, M., Cesaro, A., Malcolm, J., Quaratino, S. and Londei, M. (2005) Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis. Thorax, 60, (9), 773-780. (doi:10.1136/thx.2005.042564).

Download

Full text not available from this repository.

Original Publication URL: http://dx.doi.org/10.1136/thx.2005.042564

Description/Abstract

Background: Cystic fibrosis (CF) airways are characterised by chronic inflammation, increased interleukin (IL)-8 secretion, and neutrophil activation which are considered the principal factors of morbidity and mortality in CF patients. Optimising management of this chronic inflammatory response is therefore a key issue of basic and clinical CF research. Several reports have addressed ways to manage CF airways inflammation, and an attractive therapeutic strategy may be the inhibition of the p38-mitogen activated protein kinase (p38-MAP-k) pathway.

Methods: A new ex vivo model was used to study the mucosal inflammatory response to environmental airways stimuli. Nasal biopsy tissues from CF patients and controls were cultured ex vivo for 20 minutes, 4 hours, and 24 hours in the presence of lipopolysaccharide (LPS) from Pseudomonas aeruginosa (PA) with and without the p38-MAP-k inhibitor SB203580. Quantitative mRNA assessment, immunohistochemistry, and Western blots were used to detect the expression and modulation of inflammatory markers.

Results: PA-LPS challenge induced a time dependent mucosal inflammation indicated by rapid epithelial activation, IL-8 release, COX-2 upregulation, and neutrophil migration to the upper mucosal layers. Some of these LPS induced changes (IL-8 release and neutrophil migration) were specific to CF tissues. SB203580 significantly controlled all LPS induced mucosal changes in CF tissues.

Conclusion: These findings provide a rationale and proof of principle for the potential use of p38-MAP-k inhibitors to control inflammation in patients with CF.

Item Type: Article
Related URLs:
Keywords: interleukin 8, neutrophil, inflammation, cystic fibrosis, mitogen activated protein kinase
Subjects: R Medicine > RF Otorhinolaryngology
Q Science > QH Natural history > QH301 Biology
R Medicine > RJ Pediatrics
Divisions: University Structure - Pre August 2011 > School of Medicine > Cancer Sciences
ePrint ID: 26550
Date Deposited: 20 Apr 2006
Last Modified: 27 Mar 2014 18:15
Contact Email Address: m.londei@ich.ucl.ac.uk
URI: http://eprints.soton.ac.uk/id/eprint/26550

Actions (login required)

View Item View Item